Effects of benzothiophene on male rats following short-term oral exposure.
The systemic toxicity of benzothiophene, a sulfur-containing heterocyclic present in petroleum, coal, and their derived products, was studied in male rats following short-term oral exposure. Male Sprague-Dawley rats (130 +/- 20 g) (n = 5 per dose group) were treated with benzothiophene by gavage at dosages of 0, 2, 20 or 200 mg/kg/d for 21 d. In another study, male rats were treated with 0, 100, or 500 ppm benzothiophene via the diet for 28 d. In the gavage study, the 200 mg/kg/d rats showed depressed weight gain, increased relative liver and kidney weights, decreased relative thymus weights, and elevated levels of serum gamma-glutamyltransferase (gamma-GT), hepatic aniline hydroxylase (AH), aminopyrine N-demethylase (APDM), pentoxyresorufin O-dealkylase (PROD), glutathione S-transferase (GST), and UDP-glucuronosyltransferase (UDPGT) activities. A 4.5-fold increase in urine volume on d 14-21 and a transient, 4-fold increase in urinary ascorbic acid on d 1 were also detected. No treatment related changes in urinary N-acetylglucosaminidase (NAGA) activity were observed. Benzothiophene residues were not detected in adipose tissue, liver, and serum of rats in the 200 mg/kg rats, but a small quantity was detected in the urine. In the diet study, animals fed the 500 ppm diet had increased absolute and relative liver weights, elevated AH, APDM, and GST activities, decreased red blood cell count, and minor increases in serum urea nitrogen and glucose. In summary, benzothiophene produced adverse effects in male rats that included increased relative liver and kidney weights and increased urine output. Benzothiophene also caused increases in hepatic drug metabolizing enzyme activities of a phenobarbital type and a transient elevation in urinary ascorbic acid.
Poon
R
R
Animal Resources Division, Health Protection Branch, Ottawa, Canada. RAYMOND_POON@ISDTCP3.HWG.CA
Davis
H
H
Lecavalier
P
P
Liteplo
R
R
Yagminas
A
A
Chu
I
I
Bihun
C
C
D000284:Administration, Oral; D000821:Animal Feed / Q000032:analysis; D000818:Animals; D001205:Ascorbic Acid / Q000652:urine; D004305:Dose-Response Relationship, Drug; D004435:Eating / Q000187:drug effects; D004785:Environmental Pollutants / Q000008:administration & dosage / Q000032:analysis / Q000633:toxicity*; D007668:Kidney / Q000187:drug effects* / Q000254:growth & development / Q000502:physiology; D008099:Liver / Q000187:drug effects* / Q000254:growth & development / Q000502:physiology; D008297:Male; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology; D009929:Organ Size / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D013876:Thiophenes / Q000008:administration & dosage / Q000032:analysis / Q000633:toxicity*; D013950:Thymus Gland / Q000187:drug effects* / Q000254:growth & development; D015430:Weight Gain / Q000187:drug effects
D004785:Environmental Pollutants; D013876:Thiophenes; C088015:benzothiophene; D001205:Ascorbic Acid